Alpha Cognition (ACOG) Competitors $9.25 +0.23 (+2.55%) As of 10:14 AM Eastern Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesOwnershipSEC FilingsTrendsBuy This Stock ACOG vs. SION, CDXC, XNCR, ORIC, GHRS, TSHA, KROS, BCYC, IOVA, and UPBShould you be buying Alpha Cognition stock or one of its competitors? The main competitors of Alpha Cognition include Sionna Therapeutics (SION), ChromaDex (CDXC), Xencor (XNCR), ORIC Pharmaceuticals (ORIC), GH Research (GHRS), Taysha Gene Therapies (TSHA), Keros Therapeutics (KROS), Bicycle Therapeutics (BCYC), Iovance Biotherapeutics (IOVA), and Upstream Bio (UPB). These companies are all part of the "pharmaceutical products" industry. Alpha Cognition vs. Sionna Therapeutics ChromaDex Xencor ORIC Pharmaceuticals GH Research Taysha Gene Therapies Keros Therapeutics Bicycle Therapeutics Iovance Biotherapeutics Upstream Bio Alpha Cognition (NASDAQ:ACOG) and Sionna Therapeutics (NASDAQ:SION) are both small-cap medical companies, but which is the better investment? We will compare the two companies based on the strength of their earnings, valuation, community ranking, media sentiment, institutional ownership, risk, profitability, analyst recommendations and dividends. Is ACOG or SION more profitable? Company Net Margins Return on Equity Return on Assets Alpha CognitionN/A N/A -344.17% Sionna Therapeutics N/A N/A N/A Does the MarketBeat Community believe in ACOG or SION? Alpha Cognition and Sionna Therapeutics both received 3 outperform votes by MarketBeat users. CompanyUnderperformOutperformAlpha CognitionOutperform Votes375.00% Underperform Votes125.00% Sionna TherapeuticsOutperform Votes375.00% Underperform Votes125.00% Which has better earnings and valuation, ACOG or SION? Sionna Therapeutics has lower revenue, but higher earnings than Alpha Cognition. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioAlpha Cognition$2.93M50.60-$13.77M-$1.20-7.71Sionna TherapeuticsN/AN/AN/AN/AN/A Does the media refer more to ACOG or SION? In the previous week, Sionna Therapeutics had 7 more articles in the media than Alpha Cognition. MarketBeat recorded 8 mentions for Sionna Therapeutics and 1 mentions for Alpha Cognition. Alpha Cognition's average media sentiment score of 1.87 beat Sionna Therapeutics' score of 0.69 indicating that Alpha Cognition is being referred to more favorably in the media. Company Overall Sentiment Alpha Cognition Very Positive Sionna Therapeutics Positive Do analysts prefer ACOG or SION? Alpha Cognition currently has a consensus price target of $20.00, indicating a potential upside of 116.22%. Sionna Therapeutics has a consensus price target of $38.50, indicating a potential upside of 109.47%. Given Alpha Cognition's higher possible upside, analysts plainly believe Alpha Cognition is more favorable than Sionna Therapeutics.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Alpha Cognition 0 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 3.00Sionna Therapeutics 0 Sell rating(s) 0 Hold rating(s) 3 Buy rating(s) 0 Strong Buy rating(s) 3.00 SummaryAlpha Cognition and Sionna Therapeutics tied by winning 3 of the 6 factors compared between the two stocks. Get Alpha Cognition News Delivered to You Automatically Sign up to receive the latest news and ratings for ACOG and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart ACOG vs. The Competition Export to ExcelMetricAlpha CognitionBiological Products IndustryMedical SectorNASDAQ ExchangeMarket Cap$148.19M$3.11B$5.58B$8.67BDividend YieldN/A1.59%5.27%4.19%P/E Ratio-3.6133.8627.2320.12Price / Sales50.60477.03423.64161.29Price / CashN/A168.6838.2534.64Price / Book-8.563.497.114.72Net Income-$13.77M-$72.35M$3.23B$247.80M7 Day Performance-3.34%7.99%3.67%2.77%1 Month Performance24.50%22.61%13.11%9.75%1 Year PerformanceN/A-16.11%32.12%15.01% Alpha Cognition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)ACOGAlpha Cognition1.6343 of 5 stars$9.25+2.5%$20.00+116.2%N/A$148.19M$2.93M-3.61N/APositive NewsSIONSionna TherapeuticsN/A$13.97+2.0%$38.50+175.6%N/A$616.41MN/A0.0035CDXCChromaDex2.5768 of 5 starsN/A$9.03+∞N/A$611.50M$99.60M787.29120XNCRXencor4.045 of 5 stars$8.58+7.3%$29.50+243.8%-55.5%$610.65M$127.23M-2.68280Positive NewsORICORIC Pharmaceuticals3.9101 of 5 stars$8.47+3.7%$19.17+126.3%+13.4%$602.12MN/A-4.6580Analyst RevisionHigh Trading VolumeGHRSGH Research1.5294 of 5 stars$11.56-3.9%$30.43+163.2%+6.9%$601.44MN/A-14.6310News CoverageAnalyst RevisionTSHATaysha Gene Therapies3.8475 of 5 stars$2.79+3.0%$7.29+161.1%-33.4%$598.91M$7.22M4.43180Analyst ForecastAnalyst RevisionKROSKeros Therapeutics3.1035 of 5 stars$14.66+3.6%$37.00+152.4%-71.9%$595.42M$214.71M-2.81100Analyst DowngradeBCYCBicycle Therapeutics3.3176 of 5 stars$8.55+4.0%$25.00+192.4%-62.7%$592.12M$25.72M-2.60240Analyst RevisionIOVAIovance Biotherapeutics4.5585 of 5 stars$1.76+0.6%$13.30+655.7%-70.5%$587.72M$212.68M-1.18500Trending NewsUPBUpstream Bio1.8216 of 5 stars$10.66+15.5%$56.50+430.0%N/A$573.44M$2.30M0.0038High Trading Volume Related Companies and Tools Related Companies SION Competitors CDXC Competitors XNCR Competitors ORIC Competitors GHRS Competitors TSHA Competitors KROS Competitors BCYC Competitors IOVA Competitors UPB Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:ACOG) was last updated on 6/11/2025 by MarketBeat.com Staff From Our PartnersYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredTrump wipes out trillions overnight…Is there anybody more powerful than Donald Trump right now? In a single tariff announcement, he wiped out n...Porter & Company | SponsoredElon’s NEXT Big IPO?Cancel your internet TODAY!? Take your latest internet bill and light it on fire… then count the seconds it...Banyan Hill Publishing | SponsoredREVEALED FREE: Our top 3 stocks to own in 2025 and beyondEvery time Weiss Ratings flashed green like this, the average gain on each and every stock has been 303% (incl...Weiss Ratings | SponsoredJuly 2025 Rule Change to Impact Retirement InvestorsThere's a massive change from a new rule going into effect this July. And it's one the Big Banks are alread...Premier Gold Co | SponsoredTrump’s Exec Order #14154 could be a “Millionaire-Maker”Former Presidential Advisor, Jim Rickards, says Trump could “rewire our economy and hand millions of Americans...Paradigm Press | SponsoredHere’s How to Claim Your Stake in Elon’s Private Company, xAIEven though xAI is a private company, tech legend and angel investor Jeff Brown found a way for everyday folks...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Alpha Cognition, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Alpha Cognition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
